Inclusion Criteria:  Subjects with noticeable alopecia of the following types: androgenic alopecia, telogen effluvium and alopecia areata Experiencing active hair loss within the last 1 months but no longer than 5 years  Male/Female hair pattern loss base on:  Male presenting Norwood Hamilton Scale - Stage 1 and up to 4 Female presenting Sinclair Grade I-IV Subjects in general good health Male and female, age 18-45 years old Women of child-bearing potential that agree to abstain from pregnancy or breastfeeding during the course of the study Women of child-bearing potential are required to use a reliable method of birth control (such as an intrauterine device, birth control pills, condom with spermicidal, NuvaRing, partner with vasectomy, Implanon or other approved devices, or abstinence) at least 3 months prior to enrollment and throughout the course of the study Willing to remain on the same diet/habits (per physician recommendation) Subject is willing and able to comply with protocol requirements and all study visits Subject is willing and able to provide a written informed consent  Exclusion Criteria:  Male/Female hair pattern loss base on:  Male presenting Norwood Hamilton Scale - Stage 5 and up to 7 Female presenting Sinclair Grade V Subjects who suffer from scarring alopecia or alopecia totalis Women who are pregnant, lactating, or less than 6 months post-lactation completion, possibly pregnant or planning a pregnancy during the study period Currently participating in or recently participated in another clinical trial (within the last 90 days) Has photosensitivity to laser treatment  Previous/Current Alopecia Treatment  Has used during the six months prior to screening or is currently on any of the following medications: finasteride (or any other 5α-reductase inhibitor medications), medications with anti-androgenic properties, topical estrogen, progesterone, tamoxifen, anabolic steroids, medications which can potential cause hypertrichosis, oral glucocorticoids, lithium, phenothiazines, or other medication at the discretion of the investigator Has used during 6 months prior to screening or is currently on Minoxidil Has used oral phytotherapy within 2 months prior to study  Treatment area related  Subject who color (any type of dye) their hair less than 2 weeks prior to treatment and can't withhold dying their hair during the course of the treatment period. Has any active skin infection in the scalp or scarring Has had hair transplants, scalp reduction, current hair weave or tattooing in the target area, which makes it difficult to perform treatment and assessments Has a chronic dermatological condition (eczema, psoriasis, infection, etc.) of the scalp Has ever received radiation therapy to the scalp  Medical Conditions  History of cancer with the exception of (1) successfully treated basal cell or squamous cell carcinoma of the skin or (2) subjects with a history of successfully treated cancer that have been disease-free for five years (not in the treatment area) Any current cancer, or has had chemotherapy in the past year Bleeding disorders and/or using anti-platelet and anticoagulant medication Uncontrolled systemic disease (diabetes) or infection History of hypogonadism Has significant systemic illness Has a known underlying medical problem that could influence hair growth such as HIV infection, connective tissue disease, a thyroid condition, inflammatory bowel disease or other medical conditions, at the discretion of the investigator. Has used Accutane in the past 6 months Has a history of poor wound healing Has a history of keloid formation Has a history or evidence of heavy smoking (more than 1 package/20 cigarettes a day), any drug and/or alcohol abuse (over 500ml of 40% hard liquor a week) within the 12 months prior to study Significant concurrent illness that, in the investigator's opinion would interfere with the subject's participation in the study.